C M P Medica LLC * The Oncology Group

SHERPA: Unknown

People

  1. Hudis
    Hudis
  2. Saltz
    Saltz
  3. Seidman
    Seidman
  4. Ilson
    Ilson
  5. O'Reilly
    O'Reilly
  6. De Angelis
    De Angelis
  7. Kelsen
    Kelsen
  8. Breitbart
    Breitbart
  9. Kris
    Kris
  10. Sonoda
    Sonoda

Groups

  1. Department of Medicine (217)
  2. Solid Tumor Oncology Division (133)
  3. Survivorship Research (73)
  4. Division of Subspecialty Medicine (62)
  5. Surgery (61)
  6. Integrative Medicine (52)
  7. Breast Medicine Service (42)
  8. Gastrointestinal Oncology Service (38)
  9. Hematologic Malignancies, Division of (31)
  10. Population Sciences Research Program (29)
Search Within
Formats
  1. Journal Article (425)
  2. Conference Paper (10)
  3. Review (9)
  4. Editorial (6)
  5. Miscellaneous (5)
Groups
  1. Department of Medicine (217)
  2. Solid Tumor Oncology Division (133)
  3. Survivorship Research (73)
  4. Division of Subspecialty Medicine (62)
  5. Surgery (61)
  6. Integrative Medicine (52)

More Groups

People
  1. Barrie Cassileth (46)
  2. Bruce Minsky (17)
  3. Andrew Seidman (14)
  4. Clifford Hudis (14)
  5. Leonard Saltz (14)
  6. David Ilson (9)

More People

Years
  1. 2024 (2)
  2. 2023 (1)
  3. 2022 (2)
  4. 2021 (7)
  5. 2020 (6)
  6. 2019 (7)

More Years

Publications
  1. Oncology (Norwalk) (455)

Results (455)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Toward personalized treatment approaches in soft tissue sarcomas
    Miscellaneous

    Kelly, C.
    Oncology (Norwalk) (2024)

    Fulltext@MSK | Save
  • Defining a space for NRG1 fusion–Positive tumors in lung and GI cancers
    Editorial

    Spira, A. I.; Macarulla, T.; Neuzillet, C.; Sabari, J. K.; Schram, A.; Van Cutsem, E.
    Oncology (Norwalk) (2024)

    Fulltext@MSK | Save
  • Co–editor-in-chief introduction: Priorities and new directions
    Editorial

    Iyengar, N. M.
    Oncology (Norwalk) (2023)

    Fulltext@MSK | Save
  • Current treatment of peripheral T-cell lymphoma
    Review

    Stuver, R.; Epstein-Peterson, Z. D.; Johnson, W. T.; Khan, N.; Lewis, N.; Moskowitz, A. J.; Sauter, C. S.; Horwitz, S. M.
    Oncology (Norwalk) (2022)

    Fulltext@MSK | Save
  • Cancer-related fatigue outcome measures in integrative oncology: Evidence for practice and research recommendations
    Review

    Gentile, D.; Beeler, D, ; Wang, X. S.; Ben-Arye, E.; Zick, S.; Bao, T.; Carlson, L. E.; Ghelman, R.; Master, V. A.; Tripathy, D.; more...
    Oncology (Norwalk) (2022)

    Fulltext@MSK | Save
  • Relapsed/refractory HER2+ metastatic breast cancer
    Editorial

    Brufsky, A. M.; Gadi, V. K.; Hurvitz, S. A.; Iyengar, N. M.
    Oncology (Norwalk) (2021)

    Fulltext@MSK | Save
  • Real-world assessment of patient care and practice efficiency with the introduction of subcutaneous rituximab
    Journal Article

    Drill, E.; Qiu, A.; Shapouri, S.; Tu My, T.; Ravelo, A.; Schade, J.; Dawson, K.; Matasar, M.
    Oncology (Norwalk) (2021)

    Fulltext@MSK | Save
  • Updates in therapies of relapsed and refractory follicular lymphoma [Interview]
    Miscellaneous

    Batlevi, C. L.
    Oncology (Norwalk) (2021)

    Fulltext@MSK | Save
  • Updates in HER2-positive metastatic breast cancer
    Editorial

    Gadi, V. K.; Iyengar, N.; Isaacs, C.; Kaklamani, V.
    Oncology (Norwalk) (2021)

    Fulltext@MSK | Save
  • Management of chemotherapy-ineligible acute myeloid leukemia: Beyond hypomethylating agent monotherapy
    Editorial

    Stein, E. M.
    Oncology (Norwalk) (2021)

    Fulltext@MSK | Save

    • C M P Medica LLC * The Oncology Group – authorized name for: